Why the study?
To determine the value of mean platelet volume, des-gamma-carboxyprothrombin, and alpha-fetoprotein in the early detection of hepatocellular carcinoma.
Do MPV, DCP, and AFP levels differ between patients with HCC, liver cirrhosis, and healthy controls?
Do MPV, DCP, and AFP levels differ between patients with HCC, liver cirrhosis, and healthy controls?
MPV and DCP are significantly elevated in HCC compared to liver cirrhosis and healthy controls, suggesting MPV could serve as a cheap, non-invasive adjunctive marker for HCC detection.
DCP may outperform AFP for HCC detection; leaves open prospective validation before clinical adoption.
Background: Hepatocellular carcinoma (HCC) is the commonest primary hepatic neoplasm. The gold standard HCC biomarker is alfa-feto protein (AFP), also mean platelet volume (MPV) is increased in many inflammatory disorders and numerous neoplasms. Des-gamma-carboxyprothrombin (DCP), a protein formed during the synthesis of prothrombin with disturbance in carboxylation with vitamin K defect. Aim of the Work: To determine the value of mean platelet volume, Des gamma Carboxy prothrombin (DCP) and (AFP) in early detection of Hepatocelluler carcinoma. Patients and Methods: 105 patients were enrolled in this study, they were divided into 3 equal groups Group A: Hepatocelluler carcinoma patients (HCC) Group B: Liver cirrhosis patients Group C: Healthy Control group each is 35 patients. MPV, AFP, DCP were evaluated in all groups Results: Our results showed that: AFP, MPV and DCP were highest in HCC group, followed by CLD group and lowest in control group. The differences between all groups were significant in MPV and DCP, with no significant difference between CLD and HCC in AFP. Conclusion: Measurement of MPV is non-invasive, cheap and quick, and may therefore serve as a good predictor of HCC in patients with CLD. Low sensitivity and specificity, on the other hand, suggests that this may be an adjunctive parameter to some other markers like AFP.
No takes yet. Share an insight, caveat, or question.
Gadallah et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: